PreprintCC BY
The Covid-19 Vaccine Race: Intellectual Property, Collaboration(S), Nationalism and Misinformation
- 1Saint Louis University, School of Law
Abstract
The COVID-19 pandemic has brought a national and global vaccine race. This Article examines the race with respect to contemporary frameworks for biopharmaceutical research and development. Specifically, this Article focuses on the effect of patents, pre-production agreements, public-private partnerships, and vaccine misinformation. This Article analyzes lessons learned from the COVID-19 pandemic, advocates for promoting vaccine affordability and equity, and suggests modifications to existing preparedness frameworks to prepare for upcoming outbreaks of infectious disease.
Related
- Economic factors promoting vaccine nationalism in the face of viral evolution
- Vaccines, Bias, and the Perils of Non-peer-reviewed Studies: Fueling Misinformation and Vaccine Hesitancy
- Correcting social norm misperceptions to counter online vaccine misinformation during pandemics
- Vaccine hesitancy and misinformation in Pakistan: Challenges to childhood immunisation
- Beyond Identifying Misinformation—Helping Patients Navigate Evidence and Uncertainty in Cancer Care
BibTeX
@misc{rutschman2026covid19,
title = {{The Covid-19 Vaccine Race: Intellectual Property, Collaboration(S), Nationalism and Misinformation}},
author = {Ana Santos Rutschman},
year = {2026},
month = aug,
doi = {10.31219/osf.io/wg3b5_v1},
url = {https://doi.org/10.31219/osf.io/wg3b5_v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - The Covid-19 Vaccine Race: Intellectual Property, Collaboration(S), Nationalism and Misinformation
AU - Ana Santos Rutschman
PY - 2026
DA - 2026/08/05
DO - 10.31219/osf.io/wg3b5_v1
UR - https://doi.org/10.31219/osf.io/wg3b5_v1
AB - The COVID-19 pandemic has brought a national and global vaccine race. This Article examines the race with respect to contemporary frameworks for biopharmaceutical research and development. Specifically, this Article focuses on the effect of patents, pre-production agreements, public-private partnerships, and vaccine misinformation. This Article analyzes lessons learned from the COVID-19 pandemic, advocates for promoting vaccine affordability and equity, and suggests modifications to existing preparedness frameworks to prepare for upcoming outbreaks of infectious disease.
ER -